MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0003993
Market Cap
₹79.30 Cr
VILINBIO-ST · NSE
Share Price
₹50.95
-2.02% today
Revenue
₹42.26 Cr
FY 2025-26 · +185.4% YoY
EBITDA
₹3.19 Cr
Margin 7.5%
Net Profit
₹1.93 Cr
FY 2025-26 · +777.3% YoY
P/E (TTM)
40.0x
P/B 2.7x
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹15.25 Cr
Issued & subscribed
About Vilin Bio Med Limited
Data last updated:
Vilin Bio Med Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 29 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L24230TG2005PLC046689. Its GSTIN is 05AACCV1433D1ZW (Uttarakhand). It is a listed company as per MCA records. Its shares are listed on NSE: VILINBIO.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹15.25 Cr. It is led by directors including Madhusudhan Yadamakanti Reddy (Managing Director) and Prasanna Lakshmi Venna (Whole-Time Director).
Its last annual general meeting (AGM) was held on 02 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Hyderabad, Telangana.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹42.26 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.93 Cr (net margin 4.6%) and EBITDA of ₹3.19 Cr (EBITDA margin 7.5%). The net worth stands at ₹28.37 Cr (up 23% YoY). Total assets are valued at ₹28.58 Cr (up 11.5% YoY).
The company has about 17 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vilin Bio Med Limited. As per MCA filings, the company has satisfied charges of ₹6.67 Cr on record. Court records list 30 cases involving the company, including 2 filed by the company and 28 filed against it; 13 cases are pending. The company has 1 deal on record (1 ipo); the latest was in June 2023. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Ishita Drugs and Industries Limited with revenue of ₹15.33 Cr.
Vilin Bio Med Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003993). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vilinbiomed.co.in.
Company details
CIN L24230TG2005PLC046689
Registration Number 046689
Incorporation Date 29 June 2005
ROC Hyderabad
Listing Status Listed (NSE: VILINBIO)
Company Status Active
Date of Last AGM 02 September 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0003993
CIN history
Vilin Bio Med has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230TG2005PLC046689, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230TG2005PLC046689 | Current |
| U24230AP2005PLC046689 | Previous |
| U24230TG2005PLC046689 | Previous |
Key People
Madhusudhan Yadamakanti Reddy Managing Director Prasanna Lakshmi Venna Whole-Time Director Sasikanth Paritala Director Recognitions & Rankings of Vilin Bio Med
Contact details
Vilin Bio Med Limited's registered office is in Khairatabad, Telangana.
- Registered AddressPlot No. 43 H. No. 8 – 2 – 269/S/43 2nd Floor Sagar Co – Op Housing Society Ltd, Road No. 2 Banjara Hills Khairatabad Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryChemicals, Chemical Products, Pharmaceuticals, Medicinal Chemical & Botanical Products
Comprehensive company report
Vilin Bio Med Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vilin Bio Med operates one associated brand: Vilin Bio Med Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Vilin Bio Med Limited is engaged in manufacturing pharmaceutical formulations. | vilinbiomed.co.in |
Business activity
The main business activity of Vilin Bio Med is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vilin Bio Med Limited, buy the company report.
Financials of Vilin Bio Med Limited
FY 2025-26 filings availableVilin Bio Med Limited reported revenue of ₹42.26 Cr (up 185.3% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹42.26 Cr
+185.3% YoY
EBITDA
₹3.19 Cr
+309.0% YoY
Profit After Tax
₹1.93 Cr
+777.3% YoY
Net Worth
₹28.37 Cr
+23.0% YoY
Total Assets
₹28.58 Cr
+11.5% YoY
Total Debt
₹0.21 Cr
-91.8% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 42.26 | 14.81 | 15.80 | 12.31 | 11.21 | 11.72 | 16.81 |
| Revenue growth | +185.4% | -6.3% | +28.4% | +9.8% | -4.4% | -30.3% | - |
| EBITDA | 3.19 | 0.78 | 0.81 | 2.56 | 0.76 | 0.85 | 0.90 |
| EBITDA margin | +7.6% | +5.3% | +5.1% | +20.8% | +6.8% | +7.3% | +5.4% |
| Profit before tax | 2.84 | 0.30 | 0.21 | 1.76 | 0.03 | 0.15 | 0.19 |
| Net profit | 1.93 | 0.22 | 0.15 | 1.22 | 0.02 | 0.11 | 0.15 |
| Net profit margin | +4.6% | +1.5% | +1.0% | +9.9% | +0.2% | +0.9% | +0.9% |
| EPS (₹) | 1.37 | 0.16 | 0.12 | 1.25 | 0.10 | 0.37 | 0.49 |
| Balance sheet | |||||||
| Total assets | 28.58 | 25.64 | 29.67 | 15.61 | 12.70 | 12.88 | 11.78 |
| Net worth | 28.37 | 23.06 | 22.84 | 10.68 | 7.40 | 7.36 | 7.24 |
| Total debt | 0.21 | 2.57 | 6.83 | 4.93 | 5.30 | 5.52 | 4.53 |
| Cash & bank | 1.47 | 0.06 | 6.05 | 0.03 | 0.04 | 0.05 | 0.07 |
| Net working capital | 21.15 | 17.83 | 15.96 | 6.06 | 11.10 | 11.02 | 9.66 |
| Cash flow | |||||||
| Cash from operations | 0.70 | 0.21 | (7.42) | (1.66) | 0.21 | (1.00) | (1.46) |
| Cash from investing | (0.30) | (1.11) | 0.32 | (0.03) | 0.00 | 0.00 | (0.02) |
| Cash from financing | 1.01 | (5.10) | 8.87 | 1.68 | (0.22) | 0.98 | 1.51 |
| Particulars | Mar 2023 | Dec 2022 |
|---|---|---|
| Revenue | 3.30 | 4.91 |
| Other income | 0.00 | 0.02 |
| Total expenses | 3.06 | 3.69 |
| EBITDA | 0.24 | 1.22 |
| EBITDA margin | +7.3% | +24.8% |
| Depreciation | 0.01 | 0.08 |
| Interest | 0.20 | 0.13 |
| Profit before tax | 0.03 | 1.03 |
| Tax | 0.07 | 0.32 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 25 Oct 2026
| Particulars | Mar 2023 | Dec 2022 |
|---|---|---|
| Revenue | 3.30 | 4.91 |
| Other income | 0.00 | 0.02 |
| Total expenses | 3.06 | 3.69 |
| EBITDA | 0.24 | 1.22 |
| EBITDA margin | +7.3% | +24.8% |
| Depreciation | 0.01 | 0.08 |
| Interest | 0.20 | 0.13 |
| Profit before tax | 0.03 | 1.03 |
| Tax | 0.07 | 0.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 42.26 | 14.81 | 15.80 | 12.31 | 11.21 | 11.72 | 16.81 |
| Revenue growth | +185.4% | -6.3% | +28.4% | +9.8% | -4.4% | -30.3% | - |
| Other income | 0.00 | 0.47 | 0.32 | 0.02 | 0.00 | 0.00 | 0.01 |
| Total expenses | 39.07 | 14.03 | 14.99 | 9.75 | 10.45 | 10.87 | 15.91 |
| Employee cost | 0.00 | 0.30 | 0.80 | 0.78 | 0.85 | 0.91 | 1.20 |
| EBITDA | 3.19 | 0.78 | 0.81 | 2.56 | 0.76 | 0.85 | 0.90 |
| EBITDA margin | +7.6% | +5.3% | +5.1% | +20.8% | +6.8% | +7.3% | +5.4% |
| Depreciation | 0.28 | 0.10 | 0.13 | 0.17 | 0.22 | 0.26 | 0.31 |
| Interest | 0.07 | 0.85 | 0.79 | 0.65 | 0.51 | 0.44 | 0.41 |
| Profit before tax | 2.84 | 0.30 | 0.21 | 1.76 | 0.03 | 0.15 | 0.19 |
| Tax | 0.91 | 0.08 | 0.06 | 0.54 | 0.01 | 0.04 | 0.04 |
| Net profit | 1.93 | 0.22 | 0.15 | 1.22 | 0.02 | 0.11 | 0.15 |
| Net profit margin | +4.6% | +1.5% | +1.0% | +9.9% | +0.2% | +0.9% | +0.9% |
| EPS (₹) | 1.37 | 0.16 | 0.12 | 1.25 | 0.10 | 0.37 | 0.49 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 15.25 | 13.95 | 13.95 | 9.95 | 3.30 | 3.30 | 3.30 |
| Reserves & surplus | 13.12 | 9.11 | 8.89 | 0.73 | 4.10 | 4.06 | 3.94 |
| Shareholders' funds (net worth) | 28.37 | 23.06 | 22.84 | 10.68 | 7.40 | 7.36 | 7.24 |
| Secured loans | 0.21 | 2.57 | 6.83 | 4.93 | 5.30 | 5.52 | 4.53 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.21 | 2.57 | 6.83 | 4.93 | 5.30 | 5.52 | 4.53 |
| Total liabilities | 28.58 | 25.64 | 29.67 | 15.61 | 12.70 | 12.88 | 11.78 |
| Assets | |||||||
| Gross block | 11.26 | 9.39 | 9.39 | 9.38 | 9.36 | 1.87 | 2.13 |
| Net block | 2.87 | 1.28 | 1.39 | 1.51 | 1.65 | 1.87 | 2.13 |
| Capital work in progress | 0.00 | 1.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 7.22 | 4.41 | 4.47 | 0.88 | 2.28 | 2.06 | 2.11 |
| Sundry debtors | 15.96 | 8.56 | 5.68 | 5.60 | 7.79 | 7.65 | 7.27 |
| Cash & bank balances | 1.47 | 0.06 | 6.05 | 0.03 | 0.04 | 0.05 | 0.07 |
| Loans & advances | 2.74 | 6.86 | 2.41 | 1.54 | 1.80 | 2.22 | 2.39 |
| Total current assets | 27.39 | 19.89 | 18.61 | 8.05 | 11.91 | 11.98 | 11.84 |
| Total current liabilities | 6.24 | 2.06 | 2.65 | 1.99 | 0.81 | 0.96 | 2.18 |
| Net working capital | 21.15 | 17.83 | 15.96 | 6.06 | 11.10 | 11.02 | 9.66 |
| Total assets | 28.58 | 25.64 | 29.67 | 15.61 | 12.70 | 12.88 | 11.78 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.06 | 6.05 | 0.03 | 0.04 | 0.05 | 0.07 | 0.04 |
| Net cash from operating activities | 0.70 | 0.21 | (7.42) | (1.66) | 0.21 | (1.00) | (1.46) |
| Net cash from investing activities | (0.30) | (1.11) | 0.32 | (0.03) | 0.00 | 0.00 | (0.02) |
| Net cash from financing activities | 1.01 | (5.10) | 8.87 | 1.68 | (0.22) | 0.98 | 1.51 |
| Net change in cash | 1.41 | (5.99) | 1.77 | 0.00 | (0.01) | (0.02) | 0.03 |
| Closing cash | 1.47 | 0.06 | 6.05 | 0.03 | 0.04 | 0.05 | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +185.4% | -6.3% | +28.4% | +9.8% | -4.4% | -30.3% | - |
| EBITDA growth | +309.0% | -3.7% | -68.4% | +236.8% | -10.6% | -5.6% | - |
| PBT growth | +846.7% | +42.9% | -88.1% | +5766.7% | -80.0% | -21.1% | +9997.0% |
| Net income growth | +777.3% | +46.7% | -87.7% | +6000.0% | -81.8% | -26.7% | - |
| Revenue CAGR (3Y) | +50.9% | +9.7% | +10.5% | -9.9% | - | - | - |
| EBITDA CAGR (3Y) | +7.6% | +0.9% | -1.6% | +41.7% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +4.6% | +1.5% | +1.0% | +9.9% | +0.2% | +0.9% | +0.9% |
| Return on capital employed | - | +4.2% | +4.5% | +17.2% | +4.3% | +4.9% | +5.1% |
| Return on net worth | - | +1.0% | +1.0% | +13.8% | +0.4% | +1.6% | +2.2% |
| Debt / equity | - | 0.20 | 0.35 | 0.57 | 0.73 | 0.69 | 0.63 |
| Long-term debt / equity | - | 0.00 | 0.02 | 0.06 | 0.12 | 0.07 | 0.00 |
| Interest cover | 2.41 | 125.00 | 116.18 | 27.20 | 94.44 | 74.58 | 69.49 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.58 | 1.68 | 1.31 | 2.00 | 5.86 | 7.89 |
| Inventory turnover | - | 3.34 | 5.91 | 7.79 | 5.17 | 5.62 | 7.97 |
| Debtors turnover | - | 2.47 | 2.80 | 1.84 | 1.45 | 1.57 | 2.31 |
| EPS (₹) | 1.37 | 0.16 | 0.12 | 1.25 | 0.10 | 0.37 | 0.49 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 16.53 | 16.37 | 10.73 | 22.41 | 22.31 | 21.94 |
To see the full year-wise statements and ratios of Vilin Bio Med Limited, buy the company report.
Board of directors of Vilin Bio Med Limited
Vilin Bio Med has 4 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasanna Lakshmi Venna | Whole-Time Director | 10 Jan 2025 | 1 Years 9 Months | Current |
| Sasikanth Paritala Also directs: Wildblue Digital LLP, SVB Networks Private Limited | Director | 23 Jan 2025 | 1 Years 9 Months | Current |
| Veeraiah Chowdary Kolla Also directs: VMS Retail Private Limited, Veeramasu Private Limited | Director | 23 Jan 2025 | 1 Years 9 Months | Current |
| Madhusudhan Yadamakanti Reddy Also directs: Axia Pharma Private Limited, CNS Labs Private Limited, Bell Pharmaceuticals and Cosmetics Private Limited and 5 more | Managing Director | 03 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Vilin Bio Med Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vilin Bio Med Limitedthis company | ₹42.26 Cr (FY 2026) | ₹1.93 Cr | 4.6% | 185.3% | Hyderabad, Telangana, India | |
| Ishita Drugs and Industries Limited | ₹15.33 Cr (FY 2025) | -1.0% | Ahmedabad, Gujarat, India | |||
| Nuclotec Remedies Private Limited | ₹15.32 Cr (FY 2025) | -7.0% | New Delhi, Delhi, India | |||
| Bymaa Laboratories Private Limited | ₹15.25 Cr (FY 2025) | 8.0% | Puducherry, India | |||
| Saviour Caps Private Limited | ₹15.24 Cr (FY 2025) | -1.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Vilin Bio Med Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹6.67 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jun 2020 | 100351108 | Others | ₹90 Lakh | Satisfied | |
| 09 Feb 2009 | 10145982 | Punjab National Bank | ₹1.2 Cr | Satisfied | |
| 26 Feb 2007 | 10047964 | Punjab National Bank | ₹6.5 Lakh | Satisfied | |
| 26 Sep 2006 | 10026075 | Others | ₹4.5 Cr | Satisfied |
To see the full charge records of Vilin Bio Med Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Vilin Bio Med Limited has 1 deal on record (1 ipo); the latest was in June 2023.
Total deals
1
IPO
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | IPO | ₹12 Cr | Investors: Public Market Investors |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vilin Bio Med Limited has 30 court cases on record: 2 filed by Vilin Bio Med, 28 filed against it. 13 cases are pending and 17 are disposed.
Total cases
30
Filed by the company
2
Filed against the company
28
Pending
13
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 26 | 26 | 13 |
| High courts | 2 | 0 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Alutech Packaging Pvt.Ltd | Disposed |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by M/S. Parle Elizabeth Tools Pvt Ltd., | Disposed |
| District court, Rohtak, Haryana | Commercial suit | Filed against the company by Alutech Packaging Pvt. Ltd. | Disposed |
| District court, North, Delhi | Criminal case | Filed against the company by Union of India | Pending |
| District court, DHARWAD, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Vilin Bio Med Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vilin Bio Med Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vilin Bio Med has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCV1433D1ZW | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vilin Bio Med Limited, buy the company report.
Recent activity
Vilin Bio Med Limited has 22 board changes on record since 2010: 6 appointments and 16 cessations. The latest: Girish Girish Muktevi ceased to be Additional Director on 29 Aug 2025.
AGM
Vilin Bio Med Limited last Annual general meeting of members was held on 02 Sep 2026 as per latest MCA records.
Filing
Vilin Bio Med Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Ceased
Girish Girish Muktevi ceased to be Additional Director.
Ceased
Sasikanth Paritala ceased to be Additional Director.
Ceased
Veeraiah Chowdary Kolla ceased to be Additional Director.
Ceased
Yadamakanti Madhu Sudhan Reddy ceased to be Additional Director.
Ceased
Prasanna Lakshmi Venna ceased to be Additional Director.
Charges
A charge registered on 08 Jun 2020 via Charge ID 100351108 with Others was fully satisfied on 06 May 2025.
Charges
A charge registered on 09 Feb 2009 via Charge ID 10145982 with Punjab National Bank was fully satisfied on 06 May 2025.
Charges
A charge registered on 26 Feb 2007 via Charge ID 10047964 with Punjab National Bank was fully satisfied on 06 May 2025.
Charges
A charge registered on 26 Sep 2006 via Charge ID 10026075 with Others was fully satisfied on 06 May 2025.
Appointed
Girish Girish Muktevi was appointed as Director.
22 earlier events are in the company report.
Frequently asked questions
Vilin Bio Med is an active public limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 29 June 2005 (21+ years old) and is registered under CIN L24230TG2005PLC046689. Listed on NSE: VILINBIO.
Vilin Bio Med reported revenue of ₹42.26 Cr for FY 2025-26 (up 185.3% YoY) based on standalone financials.
Vilin Bio Med has 4 current directors:
- Madhusudhan Yadamakanti Reddy - Managing Director
- Prasanna Lakshmi Venna - Whole-Time Director
- Sasikanth Paritala - Director
- Veeraiah Chowdary Kolla - Director
The latest financial statements of Vilin Bio Med on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 02 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Vilin Bio Med is 05AACCV1433D1ZW, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Vilin Bio Med is L24230TG2005PLC046689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Vilin Bio Med is a listed company as per MCA records. Its shares are listed on NSE (symbol: VILINBIO).
Vilin Bio Med has 30 court cases on record: 2 filed by the company and 28 filed against it. 13 are pending. Most are in the district courts.
Vilin Bio Med was incorporated on 29 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vilin Bio Med has 1 deal on record (1 ipo); the latest was in June 2023.
The peers of Vilin Bio Med by revenue are Ishita Drugs and Industries Limited, Nuclotec Remedies Private Limited, Bymaa Laboratories Private Limited, Saviour Caps Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).